Please Wait
Applying Filters...
menu
    • menu
    US drug shortages reduce 16% YoY in Q1 2025; CNS drugs, antimicrobials face highest scarcities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector April 2025: Merck KGaA buys SpringWorks for US$ 3.9 bn; Swiss giants lead pharma migration to US soil

    Stock Recap
    #PipelineProspector

    Menu

    MK-869, L-754030, Emend, Aprepitant

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 15,885Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    18/11/2024 Alivus Life Sciences
    India
    		 M/s Glenmark Life Sciences Limited WC-0057n Aprepitant IH 2022-06-07 2025-06-25 Plot No. 3109, GIDC, Industrial Estate, Ankleshwar-393 002, Bharuch, Gujarat
    13/05/2020 Hetero Drugs
    India
    		 M/s. Hetero Drugs Limited, Unit -I WC-0040 Aprepitant (IH) 2022-07-04 2025-07-03 Unit-I, Survey No.213, 214 & 255,  Bonthapally Village, Jinnaram Mandal, Medak Dist, A.P